SCHEMBL7536800

SCHEMBL7536800

CC(C)(C)c1cc2ccccc2n1C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.41
HTR2C P28335 4/20 0.37
HTR2A P28223 2/20 0.37
CCR3 P51677 1/20 0.36
HTR4 Q13639 2/20 0.36
HTR6 P50406 2/20 0.36
OPRM1 P35372 3/20 0.35
OPRD1 P41143 3/20 0.35
OPRK1 P41145 3/20 0.35
OPRL1 P41146 3/20 0.35
SLC6A4 P31645 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
TP53 P04637 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8248884 0.85 TP53 (0.43) OPRM1OPRD1OPRK1OPRL1TP53
SCHEMBL5364158 0.77 OPRM1 (0.45) HTR2CHTR2ACCR3HTR4OPRM1
SCHEMBL3811103 0.75 OPRM1 (0.41) HTR2CHTR2AHTR4HTR6OPRM1
SCHEMBL16136133 0.75 KMT2A (0.46) HTR2CHTR2AHTR6SLC6A4SLC6A2
SCHEMBL21341332 0.74 HSD11B1 (0.36) TRPV4OPRM1OPRD1OPRK1OPRL1
SCHEMBL23034756 0.73 OPRM1 (0.57) HTR2CHTR2ACCR3HTR4OPRM1
SCHEMBL7535641 0.73 OPRM1 (0.40) HTR2CHTR2AHTR4OPRM1OPRD1
SCHEMBL24944391 0.72 ALDH1A1 (0.37) ACHETP53
SCHEMBL23034745 0.72 OPRM1 (0.51) HTR4OPRM1OPRD1OPRK1OPRL1
SCHEMBL20552842 0.71 PARP1 (0.43) HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733628-B9 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2002-06-12 EP disclosed
EP-0733628-B1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2000-12-27 EP disclosed
EP-0733628-A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed